• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 8-K filed by Can B Corp.

    5/6/24 4:54:44 PM ET
    $CANB
    Get the next $CANB alert in real time by email
    false 0001509957 0001509957 2024-05-06 2024-05-06 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

     

    Pursuant to Section 13 or 15(d) of

    the Securities Exchange Act of 1934

     

    Date of Report (Date of earliest event reported): May 6, 2024

     

    CAN B CORP.

    (Exact name of registrant as specified in its charter)

     

    Florida   000-55753   20-3624118

    (State or other jurisdiction

    of incorporation)

     

    (Commission

    File Number)

     

    (IRS Employer

    Identification No.)

     

    960 South Broadway, Suite 120    
    Hicksville, NY 11801   11801
    (Address of principal executive offices)   (Zip Code)

     

    (516) 595-9544

    Registrant’s telephone number, including area code

     

    Not Applicable

    Former name or former address, if changed since last report

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
       
    ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
       
    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
       
    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading Symbol(s)   Name of each exchange on which registered
    None   N/A   N/A

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging growth company ☒

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     

      

     

     

    ITEM 4.01 CHANGES IN REGISTRANT’S CERTIFYING ACCOUNTANT.

     

    Effective May 6, 2024, Can B Corp. (the “Company) dismissed BF Borgers CPA PC (“BF Borgers”) as its independent registered public accounting firm. The decision to dismiss BF Borgers was made with the recommendation and approval of the Audit Committee of the Company.

     

    BF Borgers’ audit reports on the Company’s consolidated financial statements as of and for the fiscal years ended December 31, 2023 and December 31, 2022 contained a qualification that the Company’s significant operating losses raise substantial doubt as to the Company’s ability to continue as a going concern. The audit reports did not otherwise contain a disclaimer of opinion and were not qualified or modified as to audit scope or accounting principles.

     

    During the fiscal years ended December 31, 2023 and 2022, and the subsequent interim period through the date of this report, there were no disagreements, as that term is defined in Item 304(a)(1)(iv) of Regulation S-K, between the Company and BF Borgers on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreements, if not resolved to BF Borgers’ satisfaction, would have caused BF Borgers to make reference to such disagreements in its audit reports.

     

    During the fiscal years ended December 31, 2023 and 2022, and the subsequent interim period through the date of this report, there were no reportable events within the meaning of Item 304(a)(1)(v) of Regulation S-K.

     

    The U.S. Securities and Exchange Commission (the “SEC”) has advised that, in lieu of obtaining a letter from BF Borgers stating whether or not it agrees with the statements herein, the Company may indicate that BF Borgers is not currently permitted to appear or practice before the SEC for reasons described in the SEC’s Order Instituting Public Administrative and Cease-and-Desist Proceedings Pursuant to Section 8A of the Securities Act of 1933, Sections 4C and 21C of the Securities Exchange Act of 1934 and Rule 102(e) of the Commission’s Rules of Practice, Making Findings, and Imposing Remedial Sanctions and a Cease-and-Desist Order, dated May 3, 2024.

     

      

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Date: May 6, 2024

     

      Can B Corp.
         
      By: /s/ Marco Alfonsi
      Name: Marco Alfonsi
      Title: CEO

     

      

     

    Get the next $CANB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CANB

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $CANB
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Can B Corp. Announces Holding Company Reorganization With Nascent Pharma Holdings, Inc. to Become the Publicly-Traded Parent Company

    Primary Focus on Protecting and Commercializing Cannabis Patents HICKSVILLE, N.Y., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Can B Corp. (OTCQB:CANB) ("Can B" or the "Company") today announced that it has implemented a reorganization in which a new holding company, Nascent Pharma Holdings, Inc., has become the publicly-traded parent of Can B and its subsidiaries.  As a result of the reorganization, existing shares of Can B stock have been automatically converted, on a one-for-one basis, into shares of common stock of Nascent Pharma Holdings, Inc.  The Board and executive officers of Can B will continue in the same roles at Nascent Pharma Holdings, Inc. In March 2024, Can B announced that

    10/30/24 8:00:00 AM ET
    $CANB

    Can B Corp. Completes Corporate Debt Restructuring to Position for Uplisting to National Securities Exchange

    HICKSVILLE, NY, March 15, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Can B Corp. (OTCQB:CANB) ("Can B" or the "Company"), a health and wellness company specializing in developing, producing, and selling hemp-derived cannabinoid products and durable medical devices, is pleased to announce it has successfully completed a corporate debt restructuring. Through the restructuring, Can B raised $1.55 million of new capital and extended previously due notes payable totaling $7.0 million to September 1, 2023, and December 31, 2024.  Specifically, three Promissory Notes issued to three funds in early 2022 and three Promissory Notes issued to three private investors in late 2022 were restructur

    3/15/23 11:49:00 AM ET
    $CANB

    Forever Brands Signs Manufacturing Agreement with Imbibe Wellness Solutions, LLC, a wholly owned subsidiary of Can B Corp for the Production of a new Plant Based Super Food Brand, Longevity by Brooke Burke Body TM.

    NEW YORK , July 26, 2022 /PRNewswire/ -- Forever Brands, a wholly owned subsidiary of ZA Group, Inc (OTCQB:ZAAG), has signed a manufacturing agreement with Imbibe Wellness Solutions, LLC a wholly owned subsidiary of Can B Corp (OTCQB:CANB) for the production of a new brand of Plant Based Super Food, Longevity by Brooke Burke Body TM. Can B develops consumer products at their State-of-the-Art-Research & Development facility in Lacey, WA. The Company develops, produces and test all products under the highest industry standards with independent lab testing. Can B issues Certificates of Analysis for all products! "This is a major milestone in our plan for launching Longevity on schedule. Securin

    7/26/22 8:00:00 AM ET
    $CANB

    $CANB
    SEC Filings

    View All

    SEC Form 15-12G filed by Can B Corp.

    15-12G - Can B Corp (0001509957) (Filer)

    7/16/25 11:16:04 AM ET
    $CANB

    SEC Form NT 10-K filed by Can B Corp.

    NT 10-K - Can B Corp (0001509957) (Filer)

    3/28/25 3:43:51 PM ET
    $CANB

    SEC Form EFFECT filed by Can B Corp.

    EFFECT - Can B Corp (0001509957) (Filer)

    1/27/25 12:15:04 AM ET
    $CANB

    $CANB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Can B Corp.

    SC 13G/A - Can B Corp (0001509957) (Subject)

    11/14/24 1:37:09 PM ET
    $CANB

    SEC Form SC 13G/A filed by Can B Corp. (Amendment)

    SC 13G/A - Can B Corp (0001509957) (Subject)

    2/14/24 4:38:08 PM ET
    $CANB

    SEC Form SC 13G/A filed by Can B Corp. (Amendment)

    SC 13G/A - Can B Corp (0001509957) (Subject)

    2/14/24 11:52:26 AM ET
    $CANB